Skip to main content

INTERFIRIENDO LA MECANOBIOLOGIA DE LA INTERACCION TUMOR¿ESTROMA: COMPONENTES CAVEOLARES Y SU POTENCIAL EN LA TERAPIA DEL CANCER

SAF2014-51876-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interplay between hepatic mitochondria-associated membranes, lipid metabolism and caveolin-1 in mice

  • Sala-Vila, Aleix
  • Navarro-Lérida, Inmaculada
  • Balsinde, Jesús
  • Pol, Albert
  • Pozo, Miguel A. del
This work is licensed under a Creative Commons Attribution 4.0 International License.-- et al., The mitochondria-associated membrane (MAM) is a specialized subdomain of the endoplasmic reticulum (ER) which acts as an intracellular signaling hub. MAM dysfunction has been related to liver disease. We report a high-throughput mass spectrometry-based proteomics characterization of MAMs from mouse liver, which portrays them as an extremely complex compartment involved in different metabolic processes, including steroid metabolism. Interestingly, we identified caveolin-1 (CAV1) as an integral component of hepatic MAMs, which determine the relative cholesterol content of these ER subdomains. Finally, a detailed comparative proteomics analysis between MAMs from wild type and CAV1-deficient mice suggests that functional CAV1 contributes to the recruitment and regulation of intracellular steroid and lipoprotein metabolism-related processes accrued at MAMs. The potential impact of these novel aspects of CAV1 biology on global cell homeostasis and disease is discussed., Grant support: M.A.d.P. was supported by grants SAF2011-25047, SAF2014-51876-R, and CSD2009-0016 from Spanish Ministry of Economy and Competitiveness (MINECO), 674/C/2013 from Fundació La Marató de TV3, and AICR 15-0404 from the Worldwide Cancer Research Foundation. A.P. was supported by BFU2011-23745 and CSD2009-00016 from MINECO, and La Marató de TV3. A.S.-V., who is currently holding a Miguel Servet I contract (Instituto de Salud Carlos III, Spain), was a post-doctoral fellow at CNIC from Jan 2011 to Jan 2012 thanks to a Sara Borrell contract (Instituto de Salud Carlos III, Spain). I.N.-L. was supported by a postdoctoral fellowship from the Asociación Española Contra el Cáncer (AECC). The CNIC is supported by MINECO and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense, Lipid droplets are innate immune hubs

  • Bosch, Marta
  • Sánchez-Álvarez, Miguel
  • Fajardo, Alba
  • Kapetanovic, Ronan
  • Steiner, Bernhard
  • Dutra, Filipe
  • Moreira, Luciana
  • López, Juan Antonio
  • Campo, Rocío
  • Marí, Montserrat
  • Morales-Paytuvi, Frederic
  • Tort, Olivia
  • Gubern, Albert
  • Templin, Rachel M.
  • Curson, James E. B.
  • Martel, Nick
  • Catalá, Cristina
  • Lozano, Francisco
  • Tebar, Francesc
  • Enrich, Carlos
  • Vázquez, Jesús
  • Pozo Barriuso, Miguel Ángel del
  • Sweet, Matthew J.
  • Bozza, Patricia T.
  • Gross, Steven P.
  • Parton, Robert G.
  • Pol, Albert
Lipid droplets (LDs) are the major lipid storage organelles of eukaryotic cells and a source of nutrients for intracellular pathogens. We demonstrate that mammalian LDs are endowed with a protein-mediated antimicrobial capacity, which is up-regulated by danger signals. In response to lipopolysaccharide (LPS), multiple host defense proteins, including interferon-inducible guanosine triphosphatases and the antimicrobial cathelicidin, assemble into complex clusters on LDs. LPS additionally promotes the physical and functional uncoupling of LDs from mitochondria, reducing fatty acid metabolism while increasing LD-bacterial contacts. Thus, LDs actively participate in mammalian innate immunity at two levels: They are both cell-autonomous organelles that organize and use immune proteins to kill intracellular pathogens as well as central players in the local and systemic metabolic adaptation to infection., M.B. acknowledges support from 31/U/2016 from Fundació Marató de TV3. R.K. acknowledges support from an Australian Research Council Discovery Early Career Research Award (DE130100470). B.S. is supported by an Early Postdoc Mobility fellowship from the Swiss National Science Foundation (P2ZHP3_184024). M.J.S. is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1107914). M.S.-A. was recipient of a CNIC IPP fellowship (COFUND 2014). M.M. is supported by the Instituto de Salud Carlos III (FIS PI19/01410). O.T. is founded by Amgen 2018 Competitive Grant Program. A.P., R.G.P., S.P.G., and P.T.B. have been supported by RGP0020/2015 from the Human Frontier Science Program (HFSP). A.P. is supported by the Ministerio de Ciencia e Innovación (MICINN, RTI2018-098593-B-I00), Fundació Marató de TV3 (31/U/2016), and the CERCA Programme/Generalitat de Catalunya. R.G.P. was supported by the NHMRC of Australia (program grant APP1037320 and Senior Principal Research Fellowship 569452), and the Australian Research Council Centre of Excellence in Convergent Bio-Nanoscience and Technology (CE140100036). P.T.B. is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) of Brazil and Fundaçao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). M.A.D.P. was funded by MICINN (project grants SAF2014-51876-R and SAF2017-83130-R; and IGP-SO grant MINSEV1512-07-2016) and was a Worldwide Cancer Research Foundation grantee (#15-0404). J.V. is supported by MICINN (BIO2015-67580-P) and from the Carlos III Institute of Health-Fondo de Investigación Sanitaria (PRB2, IPT13/0001—ISCIII-SGEFI/FEDER, ProteoRed). The CNIC is supported by the MICINN and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MICINN award SEV-2015-0505).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

ECM deposition is driven by caveolin-1-dependent regulation of exosomal biogenesis and cargo sorting

  • Albacete-Albacete, Lucas
  • Navarro-Lérida, Inmaculada
  • López, Juan Antonio
  • Martín-Padura, Inés
  • Astudillo, Alma M.
  • Ferrarini, Alessia
  • Van Der Heyden, Michael
  • Balsinde, Jesús
  • Orend, Gertraud
  • Vázquez, Jesús
  • Pozo, Miguel A. del
© 2020 Albacete-Albacete et al., The composition and physical properties of the extracellular matrix (ECM) critically influence tumor progression, but the molecular mechanisms underlying ECM layering are poorly understood. Tumor–stroma interaction critically depends on cell communication mediated by exosomes, small vesicles generated within multivesicular bodies (MVBs). We show that caveolin-1 (Cav1) centrally regulates exosome biogenesis and exosomal protein cargo sorting through the control of cholesterol content at the endosomal compartment/MVBs. Quantitative proteomics profiling revealed that Cav1 is required for exosomal sorting of ECM protein cargo subsets, including Tenascin-C (TnC), and for fibroblast-derived exosomes to efficiently deposit ECM and promote tumor invasion. Cav1-driven exosomal ECM deposition not only promotes local stromal remodeling but also the generation of distant ECM-enriched stromal niches in vivo. Cav1 acts as a cholesterol rheostat in MVBs, determining sorting of ECM components into specific exosome pools and thus ECM deposition. This supports a model by which Cav1 is a central regulatory hub for tumor–stroma interactions through a novel exosome-dependent ECM deposition mechanism., This study was supported by grants to M.A.d.P. from the Ministerio de Ciencia, Innovación y Universidades (MICINN: SAF2011- 25047, CSD2009-0016, SAF2014-51876-R, SAF2017-83130-, the Fundació La Marató de TV3 (674/C/2013), the Worldwide Cancer Research Foundation (AICR 15-0404) and Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa”. M.A.d.P´s group received funding from the European Union Horizon 2020 research and innovation programme under Marie Sklodowska-Curie grant agreement nº 641639. J. B. was supported by MICINN grants SAF2013-48201-R and SAF2016-80883-R, and G. O. was supported by INSERM, the University of Strasbourg, the Ligue contre le Cancer, and the Institut National du Cancer (INCa). LA-A was supported by a MICINN predoctoral fellowship associated with the Severo Ochoa Excellence program (FPI). IN-L was supported by a postdoctoral fellowship from the Asociación Española Contra el Cáncer (AECC). Miguel Sánchez Álvarez (CNIC) provided help with the manuscript preparation. Simon Bartlett (CNIC) provided English editing. The CNIC is supported by the Ministerio de Ciencia, Innovación y Universidades and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505)